← Back to Clinical Trials
Recruiting NCT07508800

NCT07508800 Effects of Brief Nature Exposure on Brain Functioning and Stress Reactivity

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07508800
Status Recruiting
Phase
Sponsor National Institutes of Health (NIH)
Condition Stress (Psychology)
Study Type OBSERVATIONAL
Enrollment 20 participants
Start Date 2026-01-01
Primary Completion 2026-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 25 Years
Study Type OBSERVATIONAL
Interventions
Nature vs. Urban walks

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 20 participants in total. It began in 2026-01-01 with a primary completion date of 2026-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study is focused on understanding the impact of time spent in nature (relative to an urban control) on stress, neural, and cardiac functioning in people experiencing high levels of stress, depression, and anxiety.

Eligibility Criteria

Inclusion Criteria: * Meets cut-off for high level of perceived stress on PSS-10 during screening (\>27 total score); Current or past depressive and anxiety disorders, if present on SCID-5 assessment, will be ncluded due to their high prevalence and overlap with perceived stress * Normal, or corrected to normal, vision (due to the visual nature of the EEG tasks) * If on psychotropic medication, stable regime for \> 1 month Exclusion Criteria: * Major medical conditions with CNS sequelae (e.g., seizure disorders, multiple sclerosis, significant, uncontrolled cardiovascular pathology) Past or present neurological problems (including seizures and head trauma resulting in neurological or cognitive sequelae) * IQ estimate \<75 on the Test of Premorbid Functioning * Current or past history of severe mental illness (e.g., bipolar schizophrenia spectrum disorder, or current or past history of substance use disorders

Frequently Asked Questions

Who can join the NCT07508800 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 25 Years, studying Stress (Psychology). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07508800 currently recruiting?

Yes, NCT07508800 is actively recruiting participants. Visit ClinicalTrials.gov or contact National Institutes of Health (NIH) to inquire about joining.

Where is the NCT07508800 trial being conducted?

This trial is being conducted at San Francisco, United States.

Who is sponsoring the NCT07508800 clinical trial?

NCT07508800 is sponsored by National Institutes of Health (NIH). The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology